88 related articles for article (PubMed ID: 18823029)
1. Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Choi KC; Bang JY; Kim C; Kim PI; Lee SR; Chung WT; Park WD; Park JS; Lee YS; Song CE; Lee HY
J Pharm Sci; 2009 Jun; 98(6):2104-12. PubMed ID: 18823029
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Jeong YI; Choi KC; Song CE
Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B-incorporated polymeric micelles composed of poly(d,l-lactide-co-glycolide)/dextran graft copolymer.
Choi KC; Bang JY; Kim PI; Kim C; Song CE
Int J Pharm; 2008 May; 355(1-2):224-30. PubMed ID: 18242900
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.
Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH
Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles.
Mooguee M; Omidi Y; Davaran S
J Pharm Sci; 2010 Aug; 99(8):3389-97. PubMed ID: 20229603
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
7. Adriamycin-incorporated nanoparticles of deoxycholic acid-conjugated dextran: antitumor activity against CT26 colon carcinoma.
Park KB; Jeong YL; Choi KC; Kim SG; Kim HK
J Nanosci Nanotechnol; 2011 May; 11(5):4240-9. PubMed ID: 21780435
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer.
Bang JY; Song CE; Kim C; Park WD; Cho KR; Kim PI; Lee SR; Chung WT; Choi KC
Arch Pharm Res; 2008 Nov; 31(11):1463-9. PubMed ID: 19023543
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(gamma-benzyl L-glutamate)/poly(ethylene oxide).
Jeong YI; Na HS; Cho KO; Lee HC; Nah JW; Cho CS
Int J Pharm; 2009 Jan; 365(1-2):150-6. PubMed ID: 18786625
[TBL] [Abstract][Full Text] [Related]
10. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
Mo SM; Oh IJ
J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
[TBL] [Abstract][Full Text] [Related]
11. Drug release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Jung SW; Jeong YI; Kim YH; Choi KC; Kim SH
J Microencapsul; 2005 Dec; 22(8):901-11. PubMed ID: 16423761
[TBL] [Abstract][Full Text] [Related]
12. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide).
Jeong YI; Shim YH; Kim C; Lim GT; Choi KC; Yoon C
J Microencapsul; 2005 Sep; 22(6):593-601. PubMed ID: 16401576
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
Misra R; Sahoo SK
Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
[TBL] [Abstract][Full Text] [Related]
20. N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance.
Li J; Zhou P; Wang Y; Chen H; Zhang C; Li R; Yang X; Wang Y
J Microencapsul; 2014; 31(3):203-10. PubMed ID: 23937210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
